Market: Copenhagen Symbol: CHR ISIN: DK0060227585
Chr. Hansen is a global bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and HMOs for a variety of foods, beverages, dietary supplements, animal feed and crop protection.
Share Data 17/09/2021
Currency DKK
Previous Close 541.00
52 Weeks % -22.81
Volume 644,853
Number of Shares 131,852,496
Market Cap (bil.) 71.3
Previous Close Currency 52 Weeks % Volume Number of Shares Market Cap (bil.)
541.00 DKK -22.81 644,853 131,852,496 71.3

Key figures, EUR million

           
Income statement (cont. operations) 2019/20 2018/19 2017/18 2016/17 2015/16
Revenue 970.0 937.4 1,097.4 1,062.5 948.9
Gross profit 584.0 576.9 600.6 578.1 505.4
EBITDA before special items 400.6 372.3 384.0 368.1 324.0
EBIT before special items 326.9 314.7 320.2 307.1 267.8
EBIT 313.0 312.4 320.2 305.7 255.6
Net financial items (13.5) (16.1) (24.1) (14.8) (16.2)
Profit from continuing operations 231.6 229.2 228.2 224.0 183.8
Profit from discontinued operations 13.4 21.0      
Profit for the year 245.0 250.2 228.2 224.0 183.8
           
Cash flow (Group) 2019/20 2018/19 2017/18 2016/17 2015/16
Cash flow from operating activities 364.6 298.6 302.4 283.7 244.8
Cash flow from investing activities (807.5) (81.6) (107.0) (176.5) (244.4)
Free cash flow (442.9) 217.0 195.4 107.2 0.4
Free cash flow before acquisitions and special items 244.5 229.1 195.9 187.8 175.2
           
Balance sheet (Group) 2019/20 2018/19 2017/18 2016/17 2015/16
Total assets* 2,853.6 2,057.8 1,861.1 1,802.1 1,715.3
Invested capital 1,238.5 972.5 1,631.5 1,581.1 1,445.0
Net working capital 208.1 220.6 189.1 174.8 147.4
Equity 893.0 797.2 771.6 768.5 730.3
Net interest-bearing debt 1,345.0 734.4 658.7 628.4 547.9
           
Key ratios 2019/20 2018/19 2017/18 2016/17 2015/16
           
Continuing operations          
Organic growth, % 6 8 9 10 12
Gross margin, % 60.2 61.5 54.7 54.4 53.3
EBITDA margin before special items, % 41.3 39.7 35.0 34.6 34.1
EBIT margin before special items, % 33.7 33.6 29.2 28.9 28.2
EBIT margin, % 32.3 33.3 29.2 28.8 26.9
R&D, % 8.0 8.1 7.3 7.0 7.1
Capital expenditure, % 12.2 12.6 9.8 10.0 8.2
           
Group          
ROIC excl. goodwill, % 32.2 37.3 38.0 40.1 39.7
ROIC, % 16.8 20.3 19.9 20.3 19.9
EPS, diluted 1.86 1.90 1.73 1.68 1.40
Net debt to EBITDA before special items 3.1x 1.8x 1.7x 1.7x 1.7x
Average number of employees (FTEs) 3,600 3,420 3,151 2,940 2,708

Following the classification of the Natural Colors business as discontinued operations in 2019/20, the business is presented separately on an aggregated level in the income statement, balance sheet and cash flow statement. In accordance with IFRS, the income statement and cash flow statement have both been restated in 2018/19, while the balance sheet has not been restated in 2018/19. The comparative figures for 2015/16 - 2017/2018 have not been restated and are not directly comparable.

Numbers are not restated and therefore not directly comparable

*Includes assets classified as held for sale in 2019/20 of EUR 202.4 million (EUR 0 million in 2018/19)